CORDIS
EU research results

CORDIS

English EN

A unique noninvasive diagnostic test based on endometrium tissue analysis, which assesses the presence or absence of endometriosis without surgery, helping the physician to make his diagnosis rapidly

Objective

Endometriosis is a chronic and disabling gynecological disease affecting 10% of women of reproductive age, representing 176 million patients worldwide. It is defined as the presence of endometrial-like tissue outside the uterus, capable of invading several organs. It is associated with acute symptoms, mainly consisting of severe pelvic pain and infertility, imposing an annual economic burden estimated at $77,46 billion in 9 European countries and $78.05 billion in the USA.

The current gold standard for diagnosis of endometriosis is an invasive surgical procedure performed under general anesthesia (laparoscopy) enabling the visualization of the lesions by the surgeon and histological confirmation. Once diagnosed, endometriosis management frequently combines surgery and non-specific hormonal therapies with limited efficacy. Since these treatments only address the symptoms and not the root causes, disease recurrence is frequent and occurs in up to 50% of the patients.

In close collaboration with international endometriosis experts, Endodiag has developed EndoSearch®, a unique noninvasive diagnostic solution based on endometrium tissue analysis, which assesses the presence or absence of endometriosis without surgery, helping the physician to make his diagnosis rapidly, cost-effectively, with a non invasive procedure and enabling him to take decisions on the most suitable patient management.

With this research programme, Endodiag is addressing a major healthcare need, clearly identified by the European Community in its statement of June 2005 at the European parliament. EndoSearch® successful validation and deployment will improve the quality of life of millions of patients while significantly reducing endometriosis-associated healthcare costs.

Coordinator

ENDODIAG

Address

4 Rue Pierre Fontaine Pepiniere Genopole Enterpris
91058 Evry

France

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU Contribution

€ 4 231 613

Project information

Grant agreement ID: 767720

Status

Ongoing project

  • Start date

    1 September 2017

  • End date

    31 August 2020

Funded under:

H2020-EU.3.1.

H2020-EU.2.3.1.

  • Overall budget:

    € 4 300 019,95

  • EU contribution

    € 4 231 613

Coordinated by:

ENDODIAG

France